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Abstract
Sjo¨gren’s syndrome (SS) is an autoimmune disease characterised by breach of
self-tolerance towards nuclear antigens resulting in high affinity circulating
autoantibodies. Although peripheral B cell disturbances have been described in SS,
with predominance of naı¨ve and reduction of memory B cells, the stage at which
errors in B cell tolerance checkpoints accumulate in SS is unknown. Here we
determined the frequency of self- and poly-reactive B cells in the circulating naı¨ve
and memory compartment of SS patients. Single CD272IgD+ naı¨ve, CD27+IgD+
memory unswitched and CD27+IgD2 memory switched B cells were sorted by
FACS from the peripheral blood of 7 SS patients. To detect the frequency of
polyreactive and autoreactive clones, paired Ig VH and VL genes were amplified,
cloned and expressed as recombinant monoclonal antibodies (rmAbs) displaying
identical specificity of the original B cells. IgVH and VL gene usage and
immunoreactivity of SS rmAbs were compared with those obtained from healthy
donors (HD). From a total of 353 VH and 293 VL individual sequences, we obtained
114 rmAbs from circulating naı¨ve (n566) and memory (n548) B cells of SS
patients. Analysis of the Ig V gene repertoire did not show significant differences in
SS vs. HD B cells. In SS patients, circulating naı¨ve B cells (with germline VH and VL
genes) displayed a significant accumulation of clones autoreactive against Hep-2
cells compared to HD (43.1% vs. 25%). Moreover, we demonstrated a progressive
increase in the frequency of circulating anti-nuclear naı¨ve (9.3%), memory
unswitched (22.2%) and memory switched (27.3%) B cells in SS patients. Overall,
these data provide novel evidence supporting the existence of both early and late
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defects in B cell tolerance checkpoints in patients with SS resulting in the
accumulation of autoreactive naı¨ve and memory B cells.
Introduction
Sjo¨gren’s syndrome (SS) is a chronic inflammatory/autoimmune disease
characterised by immune cell infiltration in the salivary and lacrimal glands
leading to the classical signs and symptoms of xerostomia (dry mouth) and
keratoconjuctivitis (dry eyes) sicca [1]. Together with exocrine dysfunction, the
hallmark of SS is the presence of circulating autoantibodies directed against
organ- and non-organ-specific autoantigens. Sera of 90% of SS patients are
characterised by the presence of antinuclear antibodies (ANA), most of which
react against the ribonucleoproteins Ro/SSA and/or La/SSB [2]. In addition,
several other autoantibody specificities, including those against alpha-fodrin,
carbonic anhydrase II and the muscarinic acetylcholine receptor 3 (M3R) have
been described in SS patients and suggested to be involved in salivary dysfunction,
especially the latter [1, 3–6].
Besides the presence of autoantibodies, SS patients are characterised by
profound disturbances in the frequency of different B cell subpopulations, both in
the peripheral compartment and in the inflamed salivary glands. Typically, SS
patients show a large predominance of circulating CD272 naı¨ve B cells and a
significant reduction of peripheral CD27+ memory B cells, in particular the
memory unswitched CD27+IgD+ subpopulation [7]. Conversely, a significant
accumulation of both CD27+ memory and (to a lesser extent) CD272 naı¨ve B
cells have been described in the SS salivary glands [7–9], possibly as a result of
increased migration/retention in the inflamed tissue, particularly in the context of
ectopic lymphoid structures which develop in ,30% of SS salivary glands [10–
12].
However, despite the evidence of profound peripheral and lesional B cell
disturbances and humoral autoimmunity, the stage of B cell development at
which the breach of self-tolerance and the onset of B cell autoreactivity develop in
SS patients is still unclear.
In physiological conditions, self-reactive (and polyreactive) B cells, which are
normally generated in the bone marrow as a consequence of random V(D)J
recombination process, are silenced before entering the mature peripheral B cell
compartments at two major tolerance checkpoints. The first occurs in the bone
marrow between the early immature and immature B cell stage, while the second
checkpoint between the transitional and the mature naı¨ve B cell stage allowing the
reduction of autoreactive/polyreactive B cells from the peripheral, circulating
naı¨ve pool [13–15]. Additionally, a third self-tolerance checkpoint ensures the
removal of most poly- and self-reactive antibodies during the IgM+ memory B cell
differentiation (pre-GC checkpoint) [13–15]. Conversely, during autoimmune
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diseases, such as rheumatoid arthritis (RA) and systemic lupus erythematosus
(SLE), perturbation of these early B cell tolerance checkpoints have been
described, as demonstrated by the increased frequency of polyreactive and self-
reactive B cells in the naı¨ve and memory peripheral B cell compartment [13, 16].
However, whether similar defects in B cell differentiation tolerance checkpoint
are present in SS patients is currently unknown. In order to address this aspect, in
this work we characterised the frequency of self- and poly-reactive circulating
naı¨ve, unswitched memory and switched memory B cells from patients with SS at
the single cell level through the cloning and in vitro expression of complete (i.e.,




Peripheral blood mononuclear cells (PBMC) were obtained from 12 patients with
a diagnosis of primary/secondary SS according to the American-European
Consensus Group classification criteria after informed consent (National Research
Ethics Service Committee London - LREC 05/Q0707/1. This board specifically
approved the collection of peripheral blood from patients with primary Sjo¨gren’s
syndrome, including the isolation of peripheral blood mononuclear cells for
downstream analysis) [18] (Table 1). Written consent was obtained from all
participants using a patient information sheet (PIS) and consent form approved
by the ethics committee stated above. Control PBMCs samples were obtained
from 7 HD including fresh naı¨ve B cells obtained at QMUL (SG and HJ) as well as
previously characterised Ig VH and VL plasmids and/or Ig VH and VL sequences
and autoreactive profiles obtained from IgD+ naı¨ve [19], IgM+ memory B cells
[20] and IgG+ memory B cells [21] kindly provided by Prof Hedda Wardemann at
Max Planck Institute for Infection Biology (Berlin, Germany).
Phenotypic characterization of circulating B cells in SS patients
PBMC were obtained from heparinized blood by centrifugation on Ficoll-Paque
gradients. Blood was diluted with 1X PBS, supplemented with 2.5 mM EDTA and
loaded over a Ficoll-Paque. Density gradient centrifugation was performed at
2000 rpm at room temperature for 25 min to separate mononuclear cells.
Mononuclear cells at the interface containing PBMC were collected and washed
twice with PBS. PBMC viability was determined by Trypan blue exclusion test.
Immunofluorescence labeling for flow cytometry was performed by staining the
purified mononuclear cells on ice with PerCP-Cy5.5 anti-human CD19 (clone
SJ25C1; BD Biosciences), APC anti-human CD27 (clone O323; eBioscience), PE
anti-human IgD (clone IA6-2; BD Biosciences), and FITC anti-human CD3 (clone
HIT3a, eBioscience) in order to differentiate CD32CD19+CD272IgD+ naı¨ve B
cells, CD32CD19+CD27+IgD+ unswitched memory B cells and
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CD32CD19+CD27+IgD2 switched memory B cells as previously described [7].
Flow cytometric analysis was performed with a FACSAria flow cytometer (Becton
Dickinson); 50,000 events were collected for each analysis.
Isolation of single human B cells by fluorescence activated cell
sorting
PBMC from 4 out of 12 SS patients (SS3, SS5, SS12, and SS13) were used for the
isolation of single CD32CD19+CD272IgD+ naı¨ve B cells. For the isolation of
single CD32CD19+CD27+IgD+ unswitched memory we used PBMC from 6 out
of 12 SS patients (SS3, SS4, SS5, SS6, SS12, and SS13) while PBMC from 7 out of
12 SS patients (SS3, SS4, SS5, SS6, SS9, SS12, and SS13) were used for the isolation
of CD32CD19+CD27+IgD2 switched memory B cells. The gating and sorting
strategy is described in Fig. 1A. Single cells were sorted on a FACSAria (Becton
Dickinson) directly into 96-well plates (Eppendorf) containing 4 ml/well of ice-
cold 0.5X PBS containing 100 mM DTT (Invitrogen), 40 U/ml RNasin
Ribonuclease Inhibitor (Promega) as previously described [17]. Plates were sealed
with adhesive PCR foil (4titude) and immediately frozen on dry ice before storage
at 280 C˚.
Single cell RT-PCR and immunoglobulin V gene amplification
cDNA was synthesized in a total volume of 14.5 ml per well in the original 96-well
sorting plate as previously described [17]. In brief, total RNA from single cells was
reverse transcribed in nuclease-free water (Qiagen) using 300 ng/ml random
hexamer primers (Roche), 25 mM each nucleotide dNTP-mix (Invitrogen),
100 mM DTT (Invitrogen), 10% NP-40 (Sigma), 40 U/ml RNasin (Promega), and
Table 1. SS patients analysed in this study.
SS patients SS1 SS2 SS3 SS4 SS5 SS6a SS8 SS9 SS10 SS11 SS12 SS13
Age 64 64 59 54 39 59 68 64 48 62 41 56
Gender F F F F F F F F F M F F
Age SS onset 52 50 43 44 32 43 66 62 43 53 26 46
Disease duration (Years) 12 14 16 10 7 16 2 2 5 9 14 10
Diagnosis pSSb pSS pSS pSS pSS pSS pSS pSS sSSb/
RAb
pSS pSS pSS
ANA + + + + + + + + + + + +
Anti-Ro/SSA + + + + + + 2 2 + + + +











Demographic and clinical characteristics of the 12 patients with Sjo¨gren’s syndrome (SS).
aPatient SS7 is the same as patient SS13 but analysed at different time points.
bpSS5primary Sjo¨gren’s syndrome; sSS5secondary Sjo¨gren’s syndrome; RA5rheumatoid arthritis.
cHCQ5Hydroxychloroquine; MTX5Methotrexate; PDN5prednisolone; N5no treatment.
doi:10.1371/journal.pone.0114575.t001
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50 U Superscript III reverse transcriptase (Invitrogen). Reverse transcription,
single-cell RT-PCR reactions, and immunoglobulin V gene amplification were
performed as described [17] with the exception of the use of a novel Cm internal
primer (GGGAATTCTCACAGGAGACGA) in the second round of the nested
PCR. Briefly, for each cell IgH and corresponding IgL chain (Igk and Igl) gene
transcripts were amplified independently by nested PCR starting from 3 ml of
cDNA as template. All PCR reactions were performed in 96-well plates in a total
volume of 40 ml per well containing 50 mM each primer [17], 25 mM each
nucleotide dNTP-mix (Invitrogen) and 1.2 U HotStar Taq DNA polymerase
(Qiagen). All nested PCR reactions with family-specific primers were performed
Fig. 1. Isolation strategy of single naı¨ve B cells and comparison of the frequencies of naı¨ve, memory
switched and unswitched B cells in SS patients and HD. (A) PBMC from SS patients were surface labeled
with fluorochrome-coupled anti-CD19, anti-CD3, anti-IgD and anti-CD27. CD19+CD32 cells were gated and
analyzed for IgD and CD27 expression. (B) The frequencies of peripheral naı¨ve (CD32CD19+CD272IgD+),
memory switched (CD32CD19+CD27+IgD–) and unswitched (CD32CD19+CD27+IgD+) B cells among all
CD19+ B cells are shown. Differences between patients and HD were statistically significant using the
nonparametric Mann-Whitney U test (p value is reported over each graph). Error bars indicate standard error
of the mean (SEM) for individual patient or control.
doi:10.1371/journal.pone.0114575.g001
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with 3 ml of unpurified first PCR product. The complete sequence of primers used
in this work is reported in S1 Table.
Ig gene sequence analysis
Aliquots of VH, Vk and Vl chain second PCR products were sequenced with the
respective reverse primer (Beckman Coulter Genomics) and the sequences were
analyzed by IgBlast (http://www.ncbi.nlm.nih.gov/igblast/) to identify germline
V(D)J gene segments with highest homology. IgH complementary determining
region (CDR)3 length and the number of positively (Histidine(H), Arginine (R),
Lysine (K)) and negatively charged (Aspartate (D), Glutamate (E)) amino acids
were determined as previously described [14, 17]. Out of 96 single naı¨ve B cell
sorted from each of the 4 SS patients, we obtained successful sequences from a
total of 119 different VH and JH regions (SS3519, SS5553, SS12517, SS13530),
73 Vk and Jk regions (SS3517, SS5531, SS1252, SS13523), and 36 Vl and Jl
regions (SS3513, SS5510, SS12510, SS1353) (S2 Table). For the memory
unswitched B cells, we obtained successful sequences from a total of 131 different
VH and JH regions (SS3533, SS4518, SS5511, SS6518, SS12526, SS13525),
74 Vk and Jk regions (SS3523, SS458, SS558, SS6511, SS12510, SS13514), and
37 Vl and Jl regions (SS358, SS456, SS552, SS655, SS1255, SS13511) (S4
Table). Finally, for the memory switched B cells, we obtained successful sequences
from a total of 103 VH and JH regions (SS3524, SS4521, SS558, SS656, SS9520,
SS12519, SS1355), 41 Vk and Jk regions (SS3514, SS453, SS557, SS654,
SS953, SS1259, SS1351), and 32 Vl and Jl regions (SS3510, SS457, SS550,
SS652, SS954, SS1254, SS1355) (S5 Table). VH, Vk and Vl sequences from SS
patients were compared with VH, Vk and Vl sequences from either freshly
obtained IgD+ naı¨ve B cells (S3 Table) or from a re-analysis of sequences from
memory unswitched and memory switched B cells from HD previously published
[20, 21] and kindly provided by Prof Hedda Wardemann at Max Planck Institute
for Infection Biology (Berlin, Germany).
Clones with matching productive VH and VL products were used for
downstream cloning and recombinant antibody expression. All productive VH
and VL products from naı¨ve B cells displayed unmutated germ line sequences
(data not shown).
Immunoglobulin Analysis Tool (IgAT) software was used to calculate the
probability of antigen-driven selection within the Ig repertoire of memory
unswitched and switched B cells [22]. IgAT uses the algorithms generated by
Chang and Casali [23] and by Lossos et al. [24] in order to identify sequences that
are indicative of an antigen-driven selection.
Expression vector cloning and monoclonal antibody production
The expression vector cloning strategy and antibody production were performed
as previously described [17]. Briefly, before cloning all PCR products were
digested with the respective restriction enzymes AgeI, Sall, BsiWI and XhoI (all
Impaired Peripheral Tolerance Checkpoints in Sjo¨gren’s Syndrome
PLOS ONE | DOI:10.1371/journal.pone.0114575 December 23, 2014 6 / 20
from NEB). Digested PCR products were ligated using the T4 DNA Ligase (NEB)
into human IgG1, Igk or Igl expression vector. Competent E. coli DH5a bacteria
(Invitrogen) were transformed at 42 C˚ with 3 ml of the ligation product. Colonies
were screened by PCR and PCR products of the expected size (650 bp for Igc1,
700 bp for Igk and 590 bp for Igl) were sequenced to confirm identity with the
original PCR products.
To express the antibodies in vitro, cells of the Human Embryonic Kidney
(HEK) 293T cell line were cultured in 6 well plates (Falcon, BD) and co-
transfected with plasmids encoding the IgH and IgL chain originally amplified
from the same B cell. Transient transfection of exponentially growing 293T cells
was performed by Polyethylenimine (Sigma) at 60–70% cell confluency. Tissue
culture supernatants with the secreted antibodies were stored at 4 C˚ with 0.05%
sodium azide. Recombinant antibody concentrations were determined by IgG
ELISA before and after purification with Protein G beads (GE Healthcare).
Characterization of polyreactivity and self-reactivity by ELISAs
and Indirect Immunofluorescence Assay (IFA)
To test the reactivity against different allo- and auto-antigens, first supernatants
were tested for polyreactivity against double and single-stranded DNA (dsDNA
and ssDNA), lipopolysaccharide (LPS) and insulin by ELISA as previously
reported [17]. Antibodies that reacted against at least two structurally diverse self-
and non-self-antigens were defined as polyreactive [14, 17]. Internal controls for
polyreactivity were kindly provided by Prof Hedda Wardemann at Max Planck
Institute for Infection Biology (Berlin, Germany) and added on each plate
consisting of the rmAbs mGO53 (negative), JB40 (low polyreactive), and ED38
(highly polyreactive) as previously reported [17]. Second, to analyse the
autoreactivity profile of the cloned antibodies, purified IgG were screened for self-
reactivity against Hep-2 cells using the indirect-immunofluorescence assay (IFA,
Orgentec).
For the polyreactivity ELISAs, antibodies were tested at 1 mg/ml and the cut-off
optical density (OD) at which all antibodies were considered reactive was
determined for each experiment based on the mean OD plus 2 standard
deviations of the mGO53 control antibody as previously described [14, 17].
Finally, for detection of ANA using Hep-2 coated slides as substrate, purified
antibodies were incubated at 10 mg/ml. Alexa Fluor 488-conjugated goat anti-
human IgG (Invitrogen) was used as detection antibody. Hep-2 staining patterns
were visualised using an Olympus BX60 microscope and digital images acquired
using identical exposure times throughout (1000 msec). ANA were scored
independently by 3 trained observers (EC, MB and SG, see acknowledgements)
and considered positive in case of concordance by at least 2 observers. Antibodies
expressed at a concentration below 1 mg/ml were excluded from the analysis.
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Statistical analysis
Differences in quantitative variables were analyzed by the Mann-Whitney U test
when comparing two groups and by the Kruskal-Wallis with Dunn’s post-test
when comparing multiple groups. x2 test with Yates’ correction when required or
Fisher’s exact test when appropriate were used to evaluate associations of
qualitative variables in the different groups. All the statistical analyses were
performed using GraphPad Prism version 5.01 for Windows (GraphPad, San
Diego, CA). A p value ,0.05 was considered statistically significant.
Results
Disturbances in peripheral B cell subpopulation in SS patients
Previous studies analyzing B cell subpopulations in SS patients have shown a
significantly reduction of circulating CD27+ memory B cells with accumulation of
CD272 naı¨ve B cells [7]. Thus, we first used 4-color flow cytometry to analyze the
frequency of naı¨ve (CD32CD19+CD272IgD+), class-switched memory B cells
(CD32CD19+CD27+IgD–) and unswitched memory B cells
(CD32CD19+CD27+IgD+) in patients with SS (Fig. 1A). This analysis confirmed
that in our cohort of SS patients the frequency of circulating CD272 naı¨ve B cells
was increased compared to HD (mean¡SD 68.5¡16.0% versus 45.8¡6.7%,
respectively), whereas the frequency of CD27+ switched (6.0¡5.2% versus
17.5¡8.1%) and unswitched (4.9¡6.6% versus 20.6¡2.4%) memory B cells was
significantly reduced (Fig. 1B, including p values).
Naı¨ve B cell Ig VH and VL gene repertoire analysis
To characterise the Ig genes expressed by naı¨ve B cells in SS patients, we sorted
CD32CD19+CD272IgD+ naı¨ve B cells as single cells by flow cytometry from
peripheral blood. The analysis of 119 V(D)J gene segments demonstrated a similar
variable heavy (VH), diversity (D) and joining (J)H gene repertoire in control and
SS naı¨ve B cells (Fig. 2A). As expected, VH3 was expressed more frequently,
followed by VH4 and VH1 both in SS patients and HD. We found a frequent usage
of JH4 followed by JH6, JH5 and JH3 while JH1 and JH2 were expressed less
frequently both in SS patients and controls, as previously shown [25]. Similarly,
no significant differences in V and J gene usage for kappa (k, 73 sequences) and
lambda (l, 36 sequences) chains were observed between SS patients and HD
(Figs. 3A and 3B). SS naı¨ve Ig gene transcripts displayed a significantly higher
frequency of positively charged IgH complementary determining regions 3
(CDR3), a feature commonly associated with autoreactive antibodies [14]
(Fig. 2B, bottom panel). However, the frequency of long CDR3, another feature
frequently displayed by polyreactive antibodies [14], was similar between HD and
SS patients (Fig. 2B, top panel). Thus, we concluded that overall there are no
major abnormalities in the Ig gene repertoire of circulating naı¨ve B cells in SS
patients as previously reported [7].
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Memory B cell Ig H and Ig L V gene repertoire and mutational
analysis
CD32CD19+IgD2CD27+ memory switched and CD32CD19+IgD+CD27+
memory unswitched B cells were sorted as single cell by flow cytometry from
peripheral blood of SS patients. The analysis of 103 V(D)J gene segments from the
Fig. 2. Ig gene analysis of naı¨ve and memory B cells from SS patients and HD. Single naı¨ve and memory
unswitched and switched B cell antibodies from SS patients and HD [19–21] were analyzed for (A) Ig VH
family and JH gene usage, and (B) IgH CDR3 aa length and number of positive charges. The absolute number
of sequences analyzed is reported over the graph. Error bars in bar graphs indicate standard error of mean
(SEM) for individual patient or control.
doi:10.1371/journal.pone.0114575.g002
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memory switched B cells and 131 V(D)J gene segments from the memory
unswitched B cells demonstrated a similar VH, D and JH gene repertoire in both
memory B cell compartments (Fig. 2A). SS memory switched and unswitched B
cells showed a similar V(D)J gene usage compared to controls. Similar to the naı¨ve
B cells from SS patients, VH3 was expressed more frequently (more than 50%)
followed by VH4 and VH1 in both memory B cell compartments. We found a
frequent usage of JH4 followed by JH6, JH5 and JH3 while JH1 and JH2 were
Fig. 3. Ig gene analysis of naı¨ve and memory B cells from SS patients and HD. Single naı¨ve and memory
unswitched and switched B cell antibodies from SS patients and HD [19–21] were analyzed for Ig Vk and Jk
(A) and Ig Vl and Jl (B) gene usage. The absolute number of sequences analyzed is reported over each
graph. Error bars in bar graphs indicate standard error of mean (SEM) for individual patient or control.
doi:10.1371/journal.pone.0114575.g003
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expressed less frequently especially in the memory switched B cells. Igk light chain
usage in the two memory B cell compartments of SS patients (k, n574 for
memory unswitched and n541 for memory switched) was similar compared to
HD (n572 for both populations) (Fig. 3A). Similarly, analysis of Vl genes from
memory unswitched (n537) and memory switched (n532) B cells from SS
patients showed no significant difference compared to HD (n536 for IgM+
memory and n544 for IgG+ memory cells, Fig. 3B). Furthermore, no significant
differences in CDR3 length and positive charges within the CDR3 were observed
in both memory unswitched and switched B cells (Fig. 2B).
Mutational analysis is normally used to study whether a B cell has experienced a
positive antigen selection. Normally, non-synonymous mutations occur less
frequently in the FRs in order to maintain the right Ig fold, whereas is positively
selected in the CDRs to increase the antigen affinity of the Ig. Thus, the
comparison of the silent (S) to replacement (R) ratios in the FR and CDR regions
is used to study the presence of antigen selection. S/R ratio calculation showed a
significant difference comparing CDRs and FRs of the IgH V genes in both
memory unswitched and memory switched SS B cells (Fig. 4A).
Additionally, we adopted the binomial distribution method recently described
by Chang and Casali [23] using the IgTA software [22] in order to calculate the
probability of antigen selection based on the somatic mutation analysis in the Ig
repertoire from memory unswitched and switched B cells. By this mean we
estimated that 19.4% and 36.7% of the sequences from the memory unswitched
and switched B cell compartment display evidence of antigen selection,
respectively (Fig. 4B).
Accumulation of autoreactive naı¨ve B cells in the peripheral blood
of SS patients suggest impairment of early tolerance checkpoints
in SS
Out of all single naı¨ve B cells isolated from the four SS patients, we managed to
obtain matching IGH, IGK and IGL chains genes of 66 naı¨ve B cells which were
then cloned into specific expression vectors and used to generate rmAbs in vitro
(SS3519; SS5520; SS1257; SS13520). As control, 45 monoclonal antibodies
were expressed from IgD+ naı¨ve B cells from HD. For full details of the repertoire
and reactivity of the naı¨ve antibodies from SS patients and HD see S2 Table and
S3 Table.
We used these antibodies to determine the frequency of polyreactivity and self-
reactivity in the naı¨ve B cell compartment of SS patients and controls. Antibody
polyreactivity was tested using ELISAs against ssDNA, dsDNA, LPS and insulin at
1 mg/ml. As shown in Fig. 5, naı¨ve B cell antibodies from SS patients showed very
low levels of polyreactivity, which was similar to HD (3.3% vs 2.4%), as previously
reported [14]. Only one antibody (SS 12n5) was found to be highly polyreactive
against all four antigens (Fig. 5). Conversely, the SS naı¨ve antibodies were more
frequently reactive towards dsDNA compared to controls (13.3% versus 2.3%,
respectively, p,0.05, Fig. 5), suggesting accumulation of autoreactive B cells.
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Autoreactive antibodies from SS naı¨ve B cells generally displayed lower binding to
dsDNA compared to highly polyreactive antibodies from memory B cells of SLE
patients such as JB40 and ED38 [17]. Thus, in order to confirm the true
autoreactivity of these antibodies, we next investigated the frequency of self-
reactive naı¨ve B cells from SS patients using the human epithelial cell line Hep-2
by IFA, a commonly used test for ANA in clinical diagnostic, as previously
reported [14, 17]. Positive results were further classified according to the Hep-2
staining pattern as anti-nuclear, anti-cytoplasmic and mixed anti-nuclear/anti-
cytoplasmic antibodies as previously reported [14]. Overall, antibodies from SS
patients displayed a significantly higher prevalence of immunoreactivity to Hep-2
compared to antibodies from HD (43.1% versus 25%, p,0.05, Fig. 6B). The
majority of antibodies from naı¨ve B cells of SS patients displayed a cytoplasmic
pattern while fewer antibodies showed antinuclear + cytoplasmic (8.6%) and
antinuclear reactivity (1.7%, Figs. 6A and 6B). Conversely, among the 25%
antibodies from HD showing positive ANA staining, none displayed a nuclear
Hep-2 pattern.
Overall, these data demonstrated, both by ELISA and IFA, that autoreactive
circulating naı¨ve B cells accumulate in the peripheral blood of SS patients.
An increased frequency of anti-nuclear autoreactivity
characterises the peripheral memory unswitched and switched B
cell compartment in SS patients
Out of all single memory switched and unswitched B cells isolated from SS
patients, we cloned and expressed the matching IGH, IGK, and IGL chains genes
from 48 individual cells (32 memory unswitched and 16 memory switched B
cells). For full details of the repertoire and reactivity of the memory unswitched
Fig. 4. Interference of antigen selection in memory B cells from SS patients. (A) Replacement:silent ratio
(R/S ratios) were calculated for the complementary determining regions CDRs (black) and framework regions
(white) for the heavy chain of both memory unswitched and switched B cells. A significant higher R/S ratio in
the CDRs was observed in memory switched vs memory unswitched B cells. (B) The graphs show the ratio of
replacement mutations in CDR1 and CDR2 (RCDR) to the total number of mutations in V region (MV) plotted
against MV for the memory unswitched and switched B cells from SS patients. The dark and the light grey area
indicate the 90% and 95% confidence limits for the probability of random mutations, respectively. A data point
outside these areas represents a sequence that was antigen selected. The data were obtained using the
Immunoglobulin Analysis Tool software [22].
doi:10.1371/journal.pone.0114575.g004
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and switched B cell antibodies from SS patients see S4 Table and S5 Table,
respectively).
We first analysed their polyreactive profile and we observed an overall
frequency of polyreactivity of 7.4% in the memory unswitched B cell antibodies
and 16.7% in the memory switched B cell antibodies (Fig. 5). The reported
frequency of polyreactive IgM and IgG memory B cell antibodies from healthy
donors is around 1% and 22%, respectively [26]. Therefore, we can conclude that
the frequency of polyreactivity in the memory unswitched and switched B cell
Fig. 5. Polyreactivity of naı¨ve and memory B cell antibodies from SS patients and HD. Naı¨ve B cell
antibodies from SS patients (n560), HD (n541) and memory B cells from SS patients (n539) were tested for
reactivity with dsDNA (top left), ssDNA (top right), LPS (bottom left) and insulin (bottom right) by ELISA. Each
graph shows the reactivity at a concentration of 1 mg/ml and it shows the result of two independent
experiments. The cut-off OD (450 nm) at which antibodies were considered reactive is shown by the
horizontal lines. Data points represent individual antibodies. Internal controls for polyreactivity (star dots) are
shown in each graph and include mGO53 (negative; [17]), JB40 (low polyreactive; [17]), and ED38 (highly
polyreactive; [17]).
doi:10.1371/journal.pone.0114575.g005
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compartment is not significantly increased in SS patients compared to normal
individuals as also reported in SLE patients [19].
We next analysed the frequency of self-reactive memory B cells from SS patients
using the Hep-2 cells by IFA. Overall, 25.9% of the antibodies derived from IgM
memory B cells displayed self-reactivity towards Hep-2 cells. The vast majority
(71.4%) of these autoreactive antibodies displayed a speckled nuclear pattern with
no cytoplasmic reactivity (Fig. 6). Interestingly, 50% of the nuclear-reactive
unswitched memory B cells displayed germ line IgH V genes, while the remaining
50% had evidence of somatic hypermutation compatible with antigen selection.
These data are extremely interesting as the reported frequency of self-reactive
memory unswitched B cells in healthy individuals is only 2% [14] and further
highlights that a perturbance in the circulating IgM memory B cells compartment,
which bears a marginal zone-like phenotype, is likely to be critical in the
development of autoimmunity in SS [7]. The analysis of the recombinant
antibodies derived from memory switched B cells showed an overall frequency of
self-reactivity towards Hep-2 cells of 45.5%. Among the autoreactive B cell clones,
the majority (60%) displayed a strong nuclear pattern with or without
cytoplasmic reactivity, again confirming an enrichment of anti-nuclear IgG
memory B cells in the circulation of SS patients.
Fig. 6. Hep-2 cell IFA self-reactivity of naı¨ve and memory B cell antibodies from SS patients and HD.
Naı¨ve and memory B cell antibodies from SS patients and HD (naı¨ve B cells) were tested for self-reactivity by
Hep-2 cell IFA assay. (A) Examples of cytoplasmic, cytoplasmic and nuclear, and nuclear Hep-2 cell staining
pattern are shown. (B) Graph bars summarize the frequency of Hep-2 cell reactive antibodies with
cytoplasmic, nuclear and cytoplasmic, nuclear reactivity, and non Hep-2 cell reactive antibodies in SS patients
(naı¨ve and memory B cell antibodies) and HD (naı¨ve B cell antibodies). P value compares ANA+ (cytoplasmic
only and nuclear ¡ cytoplasmic reactive) versus ANA– (non Hep-2 reactive) naı¨ve clones from SS patients
and HD. The percentage of self-reactivity for each population is reported over each graph. The number of
tested antibodies is indicated below each graph.
doi:10.1371/journal.pone.0114575.g006
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Discussion
The presence of profound B-cell disturbances is a pivotal feature of patients with
SS and has been demonstrated to play a fundamental role in disease pathogenesis
and clinical evolution [27, 28]. SS patients display presence of circulating immune
complexes, hypergammaglobulinemia, serum organ-specific and non-specific
autoantibodies, characteristic disturbances of peripheral B cell subsets, formation
of ectopic B cell follicles in the salivary glands, and increased risk of developing
extranodal B cell lymphomas [27]. Furthermore, evidence that treatment with B
cell depleting biological therapies is associated with clinical improvement in SS
patients confirms the importance of autoreactive B cell activation in disease
pathogenesis [29, 30]. However, the stage of B cell development at which the
breach of self-tolerance and the onset of B cell autoreactivity develop in SS
patients is still unclear.
In order to address this aspect, we single-sorted peripheral CD272IgD+ naı¨ve B
cells, CD27+IgD+ unswitched memory B cells and CD27+IgD2 switched memory
B cells and generated a large number of complete (i.e., IgH + IgL V chains linked
to a common IgG1 constant chain) rmAbs bearing identical specificity to the
original B cells [14, 17].
Using this approach, the first novel observation that we provided is that
patients with SS display a significant accumulation of autoreactive naı¨ve B cells in
the peripheral blood compared to age and sex matched healthy individuals.
Although the reactivity observed appeared to be generally of low affinity, it is
extremely interesting that unmutated germ line clones from SS patients display
increased autoreactivity. In physiological conditions, a large proportion of self-
reactive and polyreactive B cells which are normally generated in the bone marrow
during B cell development (75% and 55%, respectively) are efficiently silenced at
two major tolerance checkpoints before entering the peripheral compartment as
naı¨ve B cells [13, 31]. The first checkpoint removes most polyreactive B cells in the
bone marrow (central tolerance checkpoint) [16, 26]. The second checkpoint in
the periphery ensures that only a relatively small percentage of self-reactive and
polyreactive mature naı¨ve B cells (20% and 6%, respectively, as also confirmed in
healthy donors in our study) survive [16, 26]. This physiological fraction of
polyreactive and autoreactive naı¨ve B cells is believed to form a reservoir of
‘‘natural’’ antibodies exerting a first-line protective role by recognizing invading
pathogens [32, 33].
Thus, our evidence that an increased proportion of autoreactive CD272IgD+
naı¨ve B cells accumulate in the peripheral blood of SS patients strongly supports
the conclusion that early B cell tolerance checkpoints are significantly impaired in
SS. Similarly to other autoimmune diseases, it remains to be clarified whether this
phenomenon represents a primary event in the pathogenesis of SS promoting
breach of self-tolerance or is acquired in the course of chronic inflammatory
stimuli which mobilize autoreactive cells from the bone marrow resulting in the
peripheral accumulation of autoreactive naı¨ve B cells. Nevertheless, our data in SS
patients, together with previous reports demonstrating similar abnormalities in
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patients with SLE, RA and type 1 diabetes [13, 19], suggest that defects in early
central/peripheral B cell tolerance checkpoints are a common denominator of
autoimmune diseases.
SS patients are characterised by a distinctive distribution of peripheral B cell
subpopulations. Previous analysis [27], confirmed by data from the present work,
showed that pSS patients are characterised by characteristic qualitative B cell
disturbances with a predominance of circulating CD272 naı¨ve B cells and
dramatically diminished peripheral CD27+ memory B cells [28], especially the
circulating IgD+CD27+ memory unswitched subpopulation. Of relevance, the
reduction in the peripheral memory B cell compartment seems to be related to the
preferential migration of these cells into the inflamed glands, whereby they
account for the majority of infiltrating B cells [28]. Therefore, we cloned and
expressed rmAbs from IgD+CD27+ unswitched and IgD–CD27+ switched
memory B cells. By these means we showed that around a quarter of both IgM and
IgG circulating memory B cells display anti-nuclear immunoreactivity, demon-
strating that with the progression of B cell maturation in SS patients there is a
parallel accumulation of autoreactive memory B cells. In particular, our
demonstration that circulating IgM memory B cells frequently display an
autoreactive phenotype is extremely relevant as IgM memory B cells bearing a
marginal zone-like phenotype infiltrate SS salivary glands and are implicated in
promoting autoimmunity, chronic inflammation and evolution towards MALT
lymphomas in SS patients [7]. Nevertheless, a subset of IgM memory B cells
expressing high levels of CD25 have been shown to exert a regulatory role by
inducing FoxP3 and CTLA4 in regulatory T cells. In this regard, further studies
would be needed to ascertain whether the observed autoreactive profile of IgM
memory B cells in SS patients may also represent an attempt to revert the loss of
self-tolerance by inhibiting the autoreactive T cell compartment [34].
Of relevance, when tested towards the SS autoantigens Ro/SS-A and La/SS none
of the non-polyreactive antibodies displayed a clear reactivity. Conversely, one of
the highly polyreactive antibodies (ss12n5) reacted against both Ro/SS-A and La/
SS in ELISA but also against different ENA by Western blot and was thus
considered non-specific (data not shown). Overall, these results suggest that the
frequency of anti-Ro/SSA and anti-La/SSB autoreactive B cells is extremely low in
the peripheral compartment of SS patients possibly as a result of increased
migration to the salivary glands.
Normally, in order to prevent selection of high affinity autoreactive clones a
third tolerance checkpoint (the so called pre-germinal center checkpoint [26])
excludes self-reactive naı¨ve B cells from entering B cell follicles, thereby avoiding
their expansion and differentiation into memory B cells and plasma cells [26].
Thus, our data support the well-accepted notion that also later B cell tolerance
checkpoints are impaired in SS patients. In particular, there is clear evidence that
the mechanism of follicular exclusion is defective in SS salivary glands, allowing
autoreactive naı¨ve (and memory) B cells to enter ectopic germinal centres and
undergo clonal selection and affinity maturation [8], similarly to what has been
described in secondary lymphoid organs of patients with SLE [19]. Accordingly,
Impaired Peripheral Tolerance Checkpoints in Sjo¨gren’s Syndrome
PLOS ONE | DOI:10.1371/journal.pone.0114575 December 23, 2014 16 / 20
within the inflamed salivary glands of SS, lesional memory B cells are
characterised by high mutational load and evidence of ongoing clonal
diversification, strongly suggesting a local antigen-driven process [35]. This is
particularly evident in the context of ectopic lymphoid structures, which develop
in 30–40% of SS patients [9, 11] and are characterised by the formation of
functional germinal centres promoting the selection and differentiation of
autoreactive B cells, leading to generation of Ro/La immunoreactive plasma cells
[9, 10]. Thus, while in normal conditions, self-reactive naı¨ve and memory B cells
become anergic or produce only low affinity non-pathogenic autoantibodies [17],
in SS patients peripheral autoreactive naı¨ve and memory B cells can eventually
differentiate into autoantibodies producing plasma cells, either in secondary
lymphoid organs, followed by migration into the site of inflammation, or directly
within ELS, and thus directly contribute to the development of autoimmunity.
Although our study was not specifically designed to assess this issue, another
important observation that we provided, which confirms previous evidence in SS
and other autoimmune diseases [16, 26] is that the analysis of IgH, IgK and IgL
chain gene repertoire showed no significance differences in gene family usage
between naı¨ve or memory B cells from SS patients and healthy controls [19],
suggesting that a skewed Ig gene family usage is not responsible for the observed
accumulation of autoreactive B cells in the periphery. However, we did notice a
significantly higher frequency of positively charged amino acids within the IgH
CDR3 of SS naı¨ve B cells, a feature commonly associated with autoreactive
antibodies [14]. The increase of positively charged CDR3 in autoreactive naı¨ve B
cells with germ line sequences is of interest as accumulation of positively charged
amino acids normally results from clonal diversification in germinal centres in
secondary lymphoid organs.
Conclusion
In summary, by analysing the immunoreactivity of single cell-derived rmAbs from
naı¨ve and memory B cells we revealed the existence of defects in both early and
late B cell tolerance checkpoints in patients with Sjo¨gren’s syndrome. In
particular, i) the accumulation of circulating autoreactive naı¨ve B cells with germ
line Ig VH and VL genes suggest that the clearance of autoreactive B cell is already
impaired at the early stages of B cell development (central and/or early peripheral
tolerance checkpoints), while ii) the increased frequency of autoreactive
unswitched and switched memory B cells highlights the existence of impaired pre-
and/or post-germinal centre tolerance checkpoints in SS patients.
This work suggests a scenario whereby the continuous supply of newly
generated autoreactive naı¨ve B cells contributes to SS pathogenesis by promoting
and maintaining the autoimmune process in secondary lymphoid organs and/or
within ectopic germinal centres where impaired mechanism of follicular exclusion
allows the differentiation of high affinity autoreactive memory B cells.
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Supporting Information
S1 Table. Complete list of primers used in this study. List of primers used for Ig
VH and VL gene amplification.
doi:10.1371/journal.pone.0114575.s001 (DOC)
S2 Table. Ig gene repertoire analysis and reactivity of IgD+ single B cells from
SS patients. Clones highlighted in grey are those expressed as recombinant
antibodies.
doi:10.1371/journal.pone.0114575.s002 (XLS)
S3 Table. Ig gene repertoire analysis and reactivity of IgD+ single B cells from
HD. Clones highlighted in grey are those expressed as recombinant antibodies.
doi:10.1371/journal.pone.0114575.s003 (XLS)
S4 Table. Ig gene repertoire analysis and reactivity of IgD+CD27+ single B cells
from SS patients. Clones highlighted in grey are those expressed as recombinant
antibodies.
doi:10.1371/journal.pone.0114575.s004 (XLS)
S5 Table. Ig gene repertoire analysis and reactivity of IgD–CD27+ single B cells
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